₹400+ Crore Pharma Business Without a Factory
What if building a large pharmaceutical business did not require owning a single manufacturing facility?
HRV Pharma’s Asset-Light Model
In its feature, Business Standard looks at HRV Pharma’s asset-light model, where the company owns regulatory assets, drug master files and customer relationships while working with a network of manufacturing partners for production.
Accessing Manufacturing Infrastructure Without Factory Ownership
The model allows HRV Pharma to access established manufacturing infrastructure without carrying the capital and operational burden of owning factories. With 53 manufacturing partners, the approach is built around coordinating capabilities across a broader manufacturing network.
Building Scale Through a Manufacturing Network
The story highlights how a different approach to pharmaceutical manufacturing can create scale, flexibility and access to capacity without traditional factory ownership.
Featured in Business Standard
